These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 598599)

  • 21. Changes in obsessive/compulsive patients as measured by the Leyton Inventory before and after treatment with clomipramine.
    Allen JJ; Rack PH
    Scott Med J; 1975; 20(1 SUPPL):41-4. PubMed ID: 1098144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of anafranil in the treatment of phobic states.
    Colgan A
    Scott Med J; 1975; 20(1 SUPPL):55-60. PubMed ID: 1154016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice.
    Allsopp LF; Cooper GL; Poole PH
    Curr Med Res Opin; 1984; 9(1):64-70. PubMed ID: 6373161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of obsessional illnesses and phobic anxiety states with clomipramine.
    Marshall WK
    Br J Psychiatry; 1971 Oct; 119(551):467-8. PubMed ID: 5001955
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of clomipramine in phobic patients. Preliminary research report.
    Carey MS; Hawkinson R; Kornhaber A; Wellish CS
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):107-10. PubMed ID: 806423
    [No Abstract]   [Full Text] [Related]  

  • 27. Panic and phobic disorders in patients with obsessive compulsive disorder.
    Austin LS; Lydiard RB; Fossey MD; Zealberg JJ; Laraia MT; Ballenger JC
    J Clin Psychiatry; 1990 Nov; 51(11):456-8. PubMed ID: 2228980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Shapiro cards scale as a method of assessment of obsessional symptoms in clomipramine therapy.
    Capstick N
    Scott Med J; 1975; 20(1 SUPPL):17-20. PubMed ID: 1154009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressive reactions in the course of clomipramine therapy used in the treatment of obsessional conditions.
    Capstick N
    Scott Med J; 1975; 20(1 SUPPL):45-8. PubMed ID: 1154013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of phobic neurosis with clomipramine: a controlled clinical trial.
    Escobar JI; Landbloom RP
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):680-5. PubMed ID: 825354
    [No Abstract]   [Full Text] [Related]  

  • 31. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of sustained-release clomipramine (Anafranil SR) in the treatment of phobias: a comparison with the conventional formulation of clomipramine (Anafranil).
    Allsopp LF; Huitson A; Deering RB; Brodie NH
    J Int Med Res; 1985; 13(4):203-8. PubMed ID: 3899771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clomipramine (Anafranil) and musculo-skeletal pain in general practice: a pilot, open, non-comparative study of long-standing rheumatic pain.
    Regalado RG
    J Int Med Res; 1977; 5(1 Suppl):72-7. PubMed ID: 301105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary report on the use of clomipramine in general practice.
    Wootton LW; Bailey RI
    Scott Med J; 1975; 20(1 SUPPL):67-71. PubMed ID: 1154018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlorimipramine in obsessional states. (A pilot study).
    Capstick N
    Psychosomatics; 1971; 12(5):332-5. PubMed ID: 5172935
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparisons of various clomipramine (Anafranil) dosage regimes.
    Frank P
    J Int Med Res; 1977; 5(1 Suppl):11-5. PubMed ID: 863080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorder.
    Mavissakalian M
    Compr Psychiatry; 1983; 24(3):278-84. PubMed ID: 6347516
    [No Abstract]   [Full Text] [Related]  

  • 38. The action of chlorimipramine in obsessive-compulsive neurosis: a pilot study.
    Yaryura-Tobias JA; Neziroglu F
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):111-6. PubMed ID: 806424
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical experience in the treatment of phobic disorders.
    Marshall WK
    J Int Med Res; 1977; 5 Suppl 5():65-70. PubMed ID: 598606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.